Search global stocks & ETFs...Ctrl K
Learn Mode
DVA
Stock Profile
08-05
Recommended Metric
Score Card
Explore Scores Tab
3.07
Average
Valuation Score
Key Score
2.00
Bad
Management
4.00
Good
Growth
4.00
Good
Profitability
2.00
Bad
Fin. Health
2.00
Bad
Dividends
--
--
Analyst
1.00
Very Bad
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending Jun 28, 2027
Current
$236.97
Baseline
High
$246.75
▲
4.13%
Avg
$197.60
▼
-16.61%
Low
$146.45
▼
-38.20%
Analyst Ratings based on 13 Analysts
Strong Buy
108%
Buy
538%
Hold
646%
Sell
108%
Strong Sell
000%
DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 78,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.Read More